Diverse tumorigenic pathways in ovarian serous carcinoma. - Wikidata - awgldk - TriplyDB

Diverse tumorigenic pathways in ovarian serous carcinoma.

Diverse tumorigenic pathways in ovarian serous carcinoma.

http://www.wikidata.org/entity/Q35789009

about

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis Endometriosis and ovarian cancer: links, risks, and challenges faced RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer Proteomics of ovarian cancer: functional insights and clinical applications Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.Ovarian cancer: pathology, biology, and disease models New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.Loss of cables, a novel gene on chromosome 18q, in ovarian cancer.SNP 1772 C > T of HIF-1α gene associates with breast cancer risk in a Taiwanese population.Molecular genetic analysis of ovarian serous cystadenomas.Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.Estrogen biosynthesis and action in ovarian cancer.Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma Fallopian tube origin of supposed ovarian high-grade serous carcinomas.Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.Origins and molecular pathology of ovarian cancer.MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity.The insulin and igf-I pathway in endocrine glands carcinogenesis Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.Serous and mucinous borderline (low malignant potential) tumors of the ovary.Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk?Overexpression of S100A14 in human serous ovarian carcinoma Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens

P2860

Q26822545-23D1247A-51B9-43D5-9C5C-A8E253E484A6 Q27003273-0593B7F3-A242-43A0-A714-D3C9A919B37C Q27316858-CBECA767-0C5E-4678-9A11-B7A86846150D Q28082632-7E6BD50E-69CA-4FFD-81F3-78E5CAEF860A Q31141440-89797850-CF53-4F31-BADF-9E1B7F89632C Q33387074-3F27C44D-A2EA-446B-AF14-4B1C31AB4BE4 Q33511864-C96391E8-13B5-4289-AF67-744F1BAA4729 Q33580777-2EFBDFCA-B361-4582-BDC2-3A3EACDE6BB8 Q33807748-013E6DE4-8527-4228-BA44-4BC07B227380 Q33824552-D18C6A46-A78C-40FD-B53E-FD99A3C370A8 Q34162272-C02A77C9-DDA8-4A00-8E8E-5D1B2899A0C3 Q34189765-00AC5E24-B82C-4756-8ED6-B0606D28B0ED Q34216967-44C2AA8D-A9B1-42CF-A133-BAED78E72CC5 Q34247030-C2C0B01B-17B6-4FC6-A8B2-D047B7BB5E4E Q34308729-41F75238-B967-443A-9AC2-FAE6BA15E20F Q34312494-6662F54C-FAC8-46FC-B31A-87A51F47412F Q34361640-A617A565-F8EB-4A71-90FC-7E14A943738E Q34496401-7ACF9D2B-1A43-4292-8B1E-970169F5DACC Q34595670-43C753FE-1D10-47F9-92BE-E64450D7D397 Q34604042-ED46A5D2-2732-4E95-96E5-2AA60E430784 Q34998994-5E4873A5-B173-4D9A-86CE-241764B1BDD3 Q35060446-7F555D61-615A-492C-8BEB-DAAEE28CD6C7 Q35061331-63D7BA80-5604-4626-A89D-558FDFE476F2 Q35085393-9AEA384D-DB53-4B66-ABC1-6D5C29E23B3E Q35098091-1DCA2107-BCDB-4BC3-AE30-7938AE2D3F80 Q35209365-7403C4A9-FB0F-46D4-987E-1E99951305F6 Q35653923-21604F02-FDEF-4A50-B53E-2F32F0C01D4F Q35666387-CDF36B26-6555-40AA-B1FB-5215A68F5177 Q35770556-B02BA2CA-7383-4616-8060-0FF0A5323ED2 Q35947034-BC7FFB55-B317-4241-878D-FC1480C63FA9 Q36022324-3E119A04-A386-49A6-B9DF-7302CDC7E179 Q36068263-CC69DB54-8F60-4F8F-BD89-E8D76FC0F02A Q36105442-4297FC55-CDA7-4A42-A2D2-F893494DA767 Q36178421-F3E12642-222D-4910-9885-EE4906D8F4E3 Q36184966-64AC92C9-A9D0-4272-9191-A283D610B391 Q36229610-B1953619-A7D5-4B38-94EA-B6B627BC354F Q36457913-942EFCA2-D647-4AF7-A820-BD78BEA6EB7E Q36524069-3B87ECC5-E117-4CD3-BB77-14B95CA589C9 Q36557877-097D142F-8837-43C4-AB96-EAB917A8083A Q36694967-1C0C39AE-ADC1-40BF-823B-179117984351

P2860

Diverse tumorigenic pathways in ovarian serous carcinoma.

http://www.wikidata.org/entity/Q35789009

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Diverse tumorigenic pathways in ovarian serous carcinoma.

@ast

Diverse tumorigenic pathways in ovarian serous carcinoma.

@en

type

label

Diverse tumorigenic pathways in ovarian serous carcinoma.

@ast

Diverse tumorigenic pathways in ovarian serous carcinoma.

@en

prefLabel

Diverse tumorigenic pathways in ovarian serous carcinoma.

@ast

Diverse tumorigenic pathways in ovarian serous carcinoma.

@en

P1433

Q35789009-1AEB3C40-4CCC-46B5-9DB1-FEBED803EF60

P1476

Q35789009-4FBF5B85-4E9E-4F18-B4DA-5A75DD9693FC

P2093

Q35789009-08C0BB6C-DDB5-4640-8CB3-39104EBB6FD9

Q35789009-14E7C874-DBC2-40F1-A246-24DFCF81FA72

Q35789009-7A0572FA-D48A-4EDF-98C8-52E4A22AE941

Q35789009-ED1640C9-0B5A-4C5D-AEB3-F0AC8E06BFA1

Q35789009-FD47C0FC-A19D-4262-8FAF-6E6D9F6F7BF0

P2860

Q35789009-053DA08A-1942-489D-8DD7-8D67DC4DF3C7

Q35789009-0852EB23-640E-45E0-A99D-40E288BE9069

Q35789009-3547653B-29B7-48D5-BA5E-228BFF5DC5C5

Q35789009-64B157BB-C8EC-414F-AB46-A970B1277AF9

Q35789009-69669F28-3207-4F74-A250-424D9701EA35

Q35789009-6E1F83D4-75BB-45D9-A498-88E175E17590

Q35789009-9A333274-F7F7-48E4-BD0E-2619DA2067C0

Q35789009-A1E6ECA5-2C9A-426C-B2FB-B500964EB7D0

Q35789009-AF8880B9-A239-40DD-BD00-54172F439AA5

Q35789009-ECEFE3E2-41E1-4AE1-B530-EBC2BA0992B4

P304

Q35789009-14B6744A-E656-4EB7-95FE-AA6F39158F05

P31

Q35789009-CBDB075B-5659-45DE-9ED6-B0FB4BE244ED

P356

Q35789009-728F39A5-FC0E-4653-B930-581F86DC8558

P407

Q35789009-6DF681F2-57B7-419B-9D69-F2C305D790C7

P433

Q35789009-160B5381-C74E-49B7-B72B-D2214A9A1C87

P478

Q35789009-BB031642-5A7D-48D8-8560-1191DE145535

P577

Q35789009-0B95208B-0B4E-4AF0-BD54-31B2392A1916

P5875

Q35789009-3C6E72D5-936C-481C-8B52-AE2914AD2BC3

P698

Q35789009-E69DA529-F453-48D0-B479-C56330A3B63B

P932

Q35789009-47FEFC43-1DBF-4AD9-B7FF-7D6C571A9C02

P356

S0002-9440(10)62549-7

P1433

The American Journal of Pathology

P1476

Diverse tumorigenic pathways in ovarian serous carcinoma.

@en

P2093

Gad Singer

http://www.w3.org/2001/XMLSchema#string

Hsueh-Wei Chang

http://www.w3.org/2001/XMLSchema#string

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Robert J Kurman

http://www.w3.org/2001/XMLSchema#string

Sarah K R Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection.

Top-down morphogenesis of colorectal tumors

Counting alleles reveals a connection between chromosome 18q loss and vascular invasion.

Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

Early de novo ovarian carcinoma. A study of fourteen cases.

Human epithelial ovarian cancer allelotype.

P304

1223-1228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)62549-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11422293

http://www.w3.org/2001/XMLSchema#string

P698

11943707

http://www.w3.org/2001/XMLSchema#string

P932

1867233

http://www.w3.org/2001/XMLSchema#string